No Significant Improvement in Osteoporosis Management of Post-fragility Fracture Patients From 2010 to 2019: A National Database Study.

IF 2.1 Q2 ORTHOPEDICS
Haley D Smith, Spencer Smith, Naomi Turner, Darin Friess, Zach Working, Graham DeKeyser, Jung Yoo
{"title":"No Significant Improvement in Osteoporosis Management of Post-fragility Fracture Patients From 2010 to 2019: A National Database Study.","authors":"Haley D Smith, Spencer Smith, Naomi Turner, Darin Friess, Zach Working, Graham DeKeyser, Jung Yoo","doi":"10.5435/JAAOSGlobal-D-25-00254","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The American Orthopaedic Association initiated the \"Own the Bone\" program in 2009 to promote a more active involvement of orthopaedic surgeons in managing osteoporosis after fragility fractures. This study investigates the effectiveness of the program by examining the changes in yearly DEXA scan rates and diphosphonate prescriptions since the program's inception.</p><p><strong>Methods: </strong>Patients aged 50 to 85 years who sustained a femoral neck fracture requiring surgery from 2010 to 2019 were tracked using the PearlDiver database. The study examined annual DEXA scans within 1 year of fracture and diphosphonate treatment within 6 weeks and 1 year. Age, sex, obesity, tobacco, and alcohol use were also analyzed.</p><p><strong>Results: </strong>In total, 201,499 patients met inclusion criteria (67.0% female). Younger, predominantly female patients more often underwent DEXA scans within 1 year of fracture. Tobacco users, alcohol abusers, and obese patients were also more likely to receive scans. Annual DEXA scan rates from 2010 to 2019 ranged narrowly from 4.66% in 2012 to 5.82% in 2010, ending at 4.87% in 2019. Diphosphonate prescriptions within 1-year postfracture dropped from 5.12% in 2010 to 2.98% in 2019, with early (≤6 weeks) treatment falling from 1.07% to 0.66%, showing no sustained increase over time. Those prescribed bisphosphonates were younger, more likely female, obese, and tobacco users.</p><p><strong>Conclusion: </strong>The Own the Bone program has not successfully modified orthopaedic surgeons' approaches to managing osteoporosis. This stagnation in practice change could be due to a lack of sufficient incentives or a limited knowledge base that prevents surgeons from providing thorough osteoporosis counseling postfracture.</p>","PeriodicalId":45062,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews","volume":"9 9","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12459442/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5435/JAAOSGlobal-D-25-00254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The American Orthopaedic Association initiated the "Own the Bone" program in 2009 to promote a more active involvement of orthopaedic surgeons in managing osteoporosis after fragility fractures. This study investigates the effectiveness of the program by examining the changes in yearly DEXA scan rates and diphosphonate prescriptions since the program's inception.

Methods: Patients aged 50 to 85 years who sustained a femoral neck fracture requiring surgery from 2010 to 2019 were tracked using the PearlDiver database. The study examined annual DEXA scans within 1 year of fracture and diphosphonate treatment within 6 weeks and 1 year. Age, sex, obesity, tobacco, and alcohol use were also analyzed.

Results: In total, 201,499 patients met inclusion criteria (67.0% female). Younger, predominantly female patients more often underwent DEXA scans within 1 year of fracture. Tobacco users, alcohol abusers, and obese patients were also more likely to receive scans. Annual DEXA scan rates from 2010 to 2019 ranged narrowly from 4.66% in 2012 to 5.82% in 2010, ending at 4.87% in 2019. Diphosphonate prescriptions within 1-year postfracture dropped from 5.12% in 2010 to 2.98% in 2019, with early (≤6 weeks) treatment falling from 1.07% to 0.66%, showing no sustained increase over time. Those prescribed bisphosphonates were younger, more likely female, obese, and tobacco users.

Conclusion: The Own the Bone program has not successfully modified orthopaedic surgeons' approaches to managing osteoporosis. This stagnation in practice change could be due to a lack of sufficient incentives or a limited knowledge base that prevents surgeons from providing thorough osteoporosis counseling postfracture.

2010 - 2019年脆性骨折后患者骨质疏松管理无显著改善:一项国家数据库研究
背景:美国骨科协会于2009年发起了“拥有骨骼”计划,以促进骨科医生更积极地参与脆性骨折后骨质疏松症的治疗。本研究通过检查自计划开始以来每年DEXA扫描率和二膦酸盐处方的变化来调查该计划的有效性。方法:使用PearlDiver数据库对2010年至2019年期间因股骨颈骨折需要手术的50至85岁患者进行追踪。该研究检查了骨折1年内的年度DEXA扫描和6周和1年内的双膦酸盐治疗。还分析了年龄、性别、肥胖、吸烟和饮酒情况。结果:共有201499例患者符合纳入标准,其中67.0%为女性。年轻,以女性为主的患者更常在骨折1年内进行DEXA扫描。烟瘾者、酗酒者和肥胖患者也更有可能接受扫描。从2010年到2019年,DEXA的年扫描率从2012年的4.66%到2010年的5.82%不等,最终在2019年达到4.87%。骨折后1年内双膦酸盐处方从2010年的5.12%下降到2019年的2.98%,早期(≤6周)治疗从1.07%下降到0.66%,且没有随时间持续增加的趋势。服用双膦酸盐的患者更年轻,更有可能是女性、肥胖者和烟草者。结论:Own The Bone项目并没有成功地改变骨科医生治疗骨质疏松症的方法。这种实践变化的停滞可能是由于缺乏足够的激励或有限的知识基础,阻止外科医生在骨折后提供全面的骨质疏松症咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.60
自引率
6.70%
发文量
282
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信